Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Molecular Oncology|May 29, 2021
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapyAdviti Naik, Julie DecockFrontiers in Oncology|December 16, 2020
Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast TumorsAdviti Naik, Julie DecockPlos Computational Biology|December 16, 2014
SteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologiesAdviti Naik, Damjana Rozman, Aleš BeličFrontiers in Immunology|September 3, 2019
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast CancerAdviti Naik, Arta Monir Monjazeb, Julie DecockMolecular Therapy. Oncology|April 10, 2024
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancerAdviti Naik, Boucif Lattab, Hanan Qasem, et al.Frontiers in Genetics|January 25, 2013
Molecular Interactions between NAFLD and Xenobiotic MetabolismAdviti Naik, Aleš Belič, Ulrich M Zanger, et al.Cell Communication and Signaling : CCS|March 20, 2025
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancerAdviti Naik, Remy Thomas, Aljazi Al-Khalifa, et al.Journal of Translational Medicine|January 4, 2019
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancerGhaneya Al-Khadairi, Adviti Naik, Remy Thomas, et al.Journal of Cellular and Molecular Medicine|October 6, 2021
Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potentialAdviti Naik, Remy Thomas, Ghaneya Al-Khadairi, et al.Pageof 3